Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Clare

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Gene Therapy|June 14, 2020
Lentiviral gene therapy rescues p47<sup>phox</sup> chronic granulomatous disease and the ability to fight Salmonella infection in miceAndrea Schejtman, Walmir Cutrim Aragão-Filho, Simon Clare, et al.
Plos Neglected Tropical Diseases|October 24, 2022
The gut microbial metabolic capacity of microbiome-humanized vs. wild type rodents reveals a likely dual role of intestinal bacteria in hepato-intestinal schistosomiasisAlba Cortés, John Martin, Bruce A Rosa, et al.
Plos One|March 22, 2013
Mcph1-deficient mice reveal a role for MCPH1 in otitis mediaJing Chen, Neil Ingham, Simon Clare, et al.
Infection and Immunity|July 1, 2009
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hostsTrevor D Lawley, Simon Clare, Alan W Walker, et al.
Nature|May 27, 2021
An invariant Trypanosoma vivax vaccine antigen induces protective immunityDelphine Autheman, Cécile Crosnier, Simon Clare, et al.
Microbial Genomics|June 10, 2021
Functional analysis of colonization factor antigen I positive enterotoxigenic <i>Escherichia coli</i> identifies genes implicated in survival in water and host colonizationMoataz Abd El Ghany, Lars Barquist, Simon Clare, et al.
Scientific Reports|October 1, 2021
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel diseaseKevin J Roberts, Marion F Cubitt, Timothy M Carlton, et al.
Plos One|November 27, 2013
Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse modelAaron R Everitt, Simon Clare, Jacqueline U McDonald, et al.
Plos One|August 11, 2017
Transcriptome and proteome analysis of Salmonella enterica serovar Typhimurium systemic infection of wild type and immune-deficient miceOlusegun Oshota, Max Conway, Maria Fookes, et al.
Nature Microbiology|September 6, 2024
Primary succession of Bifidobacteria drives pathogen resistance in neonatal microbiota assemblyYan Shao, Cristina Garcia-Mauriño, Simon Clare, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Gene Therapy|June 14, 2020
Lentiviral gene therapy rescues p47<sup>phox</sup> chronic granulomatous disease and the ability to fight Salmonella infection in miceAndrea Schejtman, Walmir Cutrim Aragão-Filho, Simon Clare, et al.
Plos Neglected Tropical Diseases|October 24, 2022
The gut microbial metabolic capacity of microbiome-humanized vs. wild type rodents reveals a likely dual role of intestinal bacteria in hepato-intestinal schistosomiasisAlba Cortés, John Martin, Bruce A Rosa, et al.
Plos One|March 22, 2013
Mcph1-deficient mice reveal a role for MCPH1 in otitis mediaJing Chen, Neil Ingham, Simon Clare, et al.
Infection and Immunity|July 1, 2009
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hostsTrevor D Lawley, Simon Clare, Alan W Walker, et al.
Nature|May 27, 2021
An invariant Trypanosoma vivax vaccine antigen induces protective immunityDelphine Autheman, Cécile Crosnier, Simon Clare, et al.
Microbial Genomics|June 10, 2021
Functional analysis of colonization factor antigen I positive enterotoxigenic <i>Escherichia coli</i> identifies genes implicated in survival in water and host colonizationMoataz Abd El Ghany, Lars Barquist, Simon Clare, et al.
Scientific Reports|October 1, 2021
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel diseaseKevin J Roberts, Marion F Cubitt, Timothy M Carlton, et al.
Plos One|November 27, 2013
Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse modelAaron R Everitt, Simon Clare, Jacqueline U McDonald, et al.
Plos One|August 11, 2017
Transcriptome and proteome analysis of Salmonella enterica serovar Typhimurium systemic infection of wild type and immune-deficient miceOlusegun Oshota, Max Conway, Maria Fookes, et al.
Nature Microbiology|September 6, 2024
Primary succession of Bifidobacteria drives pathogen resistance in neonatal microbiota assemblyYan Shao, Cristina Garcia-Mauriño, Simon Clare, et al.
Pageof 16